Compounds > n-methyl-3,4-methylenedioxyamphetamine

n-methyl-3,4-methylenedioxyamphetamine and 3-methyladenine

n-methyl-3,4-methylenedioxyamphetamine has been researched along with 3-methyladenine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, LC; Huang, YS; Kao, TJ; Li, IH; Lin, YY; Ma, KH; Weng, SJ; Yen, TY1
Chiu, CH; Huang, YS; Kao, LT; Li, IH; Lin, YY; Ma, KH; Shih, JH; Shiue, CY; Yeh, TY1

Other Studies

2 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and 3-methyladenine

ArticleYear
Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity.
    Neurotoxicology, 2016, Volume: 52

    Topics: Adenine; Animals; Autophagy; Benzylamines; Brain Stem; Cells, Cultured; Citalopram; Dose-Response Relationship, Drug; Down-Regulation; Fluorine Radioisotopes; Functional Neuroimaging; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Neurites; Neuroprotective Agents; Phagosomes; Positron-Emission Tomography; Rats; Serotonergic Neurons; Serotonin Plasma Membrane Transport Proteins

2016
Autophagy inhibition plays a protective role against 3, 4-methylenedioxymethamphetamine (MDMA)-induced loss of serotonin transporters and depressive-like behaviors in rats.
    Pharmacological research, 2019, Volume: 142

    Topics: Adenine; Animals; Autophagy; Behavior, Animal; Brain; Depression; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Rats, Sprague-Dawley; Serotonergic Neurons; Serotonin Plasma Membrane Transport Proteins

2019